Health And Human Services, Department Of- National Institutes Of Health- National Institute Of Health Nih- OD
Preclinical Study
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension - The National Institutes of Health ( NIH) intends to negotiate on a sole- source basis with the University of Illinois at Chicago ( UIC) for preclinical animal research services to evaluate the therapeutic effects of soluble adenylyl cyclase ( sAC) inh
Preclinical animal research services Preclinical animal research services to evaluate the therapeutic effects of soluble adenylyl cyclase ( SAC) inhibition on pulmonary arterial hypertension ( PAH) using an established endothelial cell specific CAV1 knockout ( EC CAV1 KO) murine model.
Bid Close Date: